Fan Yang

Ms. Fan Yang

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2022 in Molecules
Verified
Journal Article
Open access
PDF file
FYFan Yang
Fan Yang
DHDenice van Herwerden
Denice van Herwerden
HPHugues Preud'homme
Hugues Preud'homme
Saer SamanipourSaer Samanipour
Saer Samanipour
High-resolution mass spectrometry is a promising technique in non-target screening (NTS) to monitor contaminants of emerging concern in complex samples. Current chemical identification strategies in NTS experiments typically depend on spectral libraries, chemical databases, and in silico fragmentation tools. However, small molecule identification remains challenging due to the lack of orthogonal sources of information (e.g., unique fragments). Collision cross section (CCS) values measured by ion mobility spectrometry (IMS) offer an additional identification dimension to increase the confidence level. Thanks to the advances in analytical instrumentation, an increasing application of IMS hybrid with high-resolution mass spectrometry (HRMS) in NTS has been reported in the recent decades. Several CCS prediction tools have been developed. However, limited CCS prediction methods were based on a large scale of chemical classes and cross-platform CCS measurements. We successfully developed two prediction models using a random forest machine learning algorithm. One of the approaches was based on chemicals’ super classes; the other model was direct CCS prediction using molecular fingerprint. Over 13,324 CCS values from six different laboratories and PubChem using a variety of ion-mobility separation techniques were used for training and testing the models. The test accuracy for all the prediction models was over 0.85, and the median of relative residual was around 2.2%. The models can be applied to different IMS platforms to eliminate false positives in small molecule identification.

9 April 2026 in medRxiv
Verified
Preprint
Open access
ITIoanna Tsiara
Ioanna Tsiara
EVEfstathia Vouzaxaki
Efstathia Vouzaxaki
JEJoakim Ekström
Joakim Ekström
NRNatallia Rameika
Natallia Rameika
FYFan Yang
Fan Yang
Daniel GlobischDaniel Globisch
Daniel Globisch
Cancer-related casualties are the most common cause of death worldwide. The discovery of biomarkers is of utmost importance for diagnosis and disease monitoring. Herein, we performed a comprehensive metabolomics biomarker discovery effort in plasma from 615 lung, ovarian and colorectal cancer patients at diagnosis and 95 non-cancerous control subjects. This pan-cancer investigation identified specific panels of metabolites in the entire sample cohort with a high discriminating power and demonstrated by combined ROC AUC values of up to 0.95. The identified metabolites are mainly associated with lipid and amino acid metabolism as well as xenobiotic transformation. These metabolite panels of high predictive power provide new metabolic insights in these cancers and demonstrate the potential of metabolomics for improved diagnosis and monitoring disease progression.